EA
CELG

Euclid Advisors’s Celgene Corp CELG Stock Holding History

Euclid Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-17,850
Closed -$1.76M – 549
2016
Q2 		$1.76M Sell
17,850
-8,645
-33% -$894K 0.08% 283
2016
Q1 		$2.65M Sell
26,495
-43,534
-62% -$4.48M 0.1% 248
2015
Q4 		$8.39M Buy
+70,029
New +$8.1M 0.26% 137
2015
Q3 		– Sell
-134,722
Closed -$15.6M – 502
2015
Q2 		$15.6M Sell
134,722
-156,368
-54% -$17.9M 0.31% 103
2015
Q1 		$33.6M Buy
+291,090
New +$34.8M 0.62% 36
2014
Q4 		– Sell
-406,435
Closed -$38.5M – 558
2014
Q3 		$38.5M Buy
406,435
+26,250
+7% +$2.37M 0.28% 82
2014
Q2 		$32.6M Sell
380,185
-68,211
-15% -$5.19M 0.23% 104
2014
Q1 		$31.3M Buy
448,396
+118,800
+36% +$9.41M 0.24% 93
2013
Q4 		$27.8M Sell
329,596
-16,130
-5% -$1.28M 0.23% 96
2013
Q3 		$26.6M Buy
345,726
+67,144
+24% +$4.71M 0.27% 89
2013
Q2 		$16.3M Buy
+278,582
New +$16.8M 0.21% 124

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Euclid Advisors's CELG Position: Q3 2016 in Review

Euclid Advisors sold out of Celgene Corp (CELG) in Q3 2016, closing a stake of 17,850 shares — an estimated $1.76M sold.

Euclid Advisors first reported a position in CELG in Q2 2013 and held it in 11 quarters. The position peaked at $38.5M in Q3 2014. 1,277 funds tracked by Wall St. Rank hold CELG as of Q3 2016.

  • Euclid Advisors reported no remaining Celgene Corp position as of Q3 2016 after selling out during the quarter.
  • Euclid Advisors sold 17,850 Celgene Corp shares in Q3 2016, an estimated $1.76M.
  • Euclid Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 11 quarters.
  • Euclid Advisors's Celgene Corp position peaked at $38.5M in Q3 2014.
  • 1,277 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.